WASHINGTON -- Children who are healthy but abnormally short will be able to have injections of growth hormone in hopes of gaining 1 to 3 more inches of height, the Food and Drug Administration said ...
Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved three new indications for ...
The FDA has approved three new pediatric indications for somapacitan-beco, a once-weekly, long-acting growth hormone ...
Growth hormone treatment is a safe and effective therapy that’s often used to treat children and adults with a deficiency in human growth hormone (also known as HGH or somatropin). Naturally-occurring ...
In today’s Pharmaceutical Executive Daily, the FDA approves an expanded indication for Palynziq in patients aged 12 and older ...
Children born small for gestational age (SGA) exhibited impaired glucose-insulin metabolism, similar to children with obesity, which worsened under growth hormone therapy. In contrast, children with ...
NEW YORK (Reuters Health) - Daily injections of growth hormone may help reduce pain and improve the quality of life in some patients with fibromyalgia, new findings of a small study suggest.
The human growth hormone business is a $2 billion industry. Feb. 12, 2008— -- Marie Miano, like some professional athletes, takes human growth hormone — but she has a prescription. "I feel like a ...
Researchers at Ohio University have discovered what may be a new way to fight lung cancer that is resistant to other ...
Growth hormone, produced by the pituitary gland, plays a critical role in cell regeneration, growth, and maintaining healthy body tissue, including the brain and vital organs. While synthetic human ...
Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved three new indications for once-weekly Sogroya (R) (somapacitan-beco) injection 5 mg, 10 mg, or 15 mg, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results